Abstract
Degeneration of dopamine (DA) neurons in the substantia nigra pars compacta (SNc) causes the motor symptoms (e.g. tremor, muscle rigidity, bradykinesia, postural instability) of Parkinson’s disease (PD). It is generally agreed that replacing these neurons will provide better motor symptom relief and fewer side effects than current pharmacotherapies. One potential approach to this is up-regulating endogenous DA neurogenesis in SNc. In the present study, we conducted bioinformatics analyses to identify signalling pathways that control expression of Pax6 and Msx1 genes, which have been identified as potentially important neurogenic regulators in the adult midbrain. From this Valproic acid (VPA) was identified as a regulator of these pathways, and we tested VPA for its ability to regulate midbrain neurogenesis in adult mice. VPA was infused directly into the midbrain of adult NesCreERT2/R26eYFP mice using osmotic pumps attached to implanted cannula. These mice enable permanent eYFP+ labelling of adult Nestin-expressing neural precursor cells and their progeny/ontogeny. VPA did not affect the number of eYFP+ midbrain cells, but significantly reduced the number of Pax6+, Pax6+/NeuN+, eYFP+/NeuN+ and eYFP−/NeuN+ cells. However, this reduction in NeuN expression was probably via VPA’s Histone de-acetylase inhibitory properties rather than reduced neuronal differentiation by eYFP + cells. We conclude that Pax6 and Msx1 are not viable targets for regulating neurogenesis in the adult midbrain.
References
Noyes K, Liu H, Li Y, Holloway R, Dick AW (2006) Economic burden associated with Parkinson’s disease on elderly medicare beneficiaries. Mov Disord 21:362–372
Braybrook M, O’Connor S, Churchward P, Perera T, Farzanehfar P, Horne M (2016) An Ambulatory Tremor Score for Parkinson’s disease. J Parkinson’s Dis 6:723–731
Farzanehfar P (2016) Towards a better treatment option for Parkinson’s disease: a review of adult neurogenesis. Neurochem Res, 41:3161–3170
Farzanehfar P (2016) An anatomical and single-cell gene expression characterisation of putative neurogenesis from nestin-expressing cells in the adult mouse midbrain, Ph.D. thesis, The University of Melbourne.
Shan X, Chi L, Bishop M, Luo C, Lien L, Zhang Z et al (2006) Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phyenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s disease-like mice. Stem Cells 24:1280–1287
Farzanehfar P, Lu SS, Dey A, Musiienko D, Baagil H, Horne MK et al (2017) Evidence of functional duplicity of Nestin expression in the adult mouse midbrain. Stem Cell Res 19:82–93
Imayoshi I, Ohtsuka T, Metzger D, Chambon P, Kageyama R (2006) Temporal regulation of Cre recombinase activity in neural stem cells. Genesis 44:233–238
Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM et al (2001) Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1:4
Downing T (2013) Biomaterials for cell engineering and regenerative medicine University of California, Berkeley
Chang C-Z, Wu S-C, Lin C-L, Kwan A-L (2015) Valproic acid attenuates intercellular adhesion molecule-1 and E-selectin through a chemokine ligand 5 dependent mechanism and subarachnoid hemorrhage induced vasospasm in a rat model. J Inflamm 12:27
OsUmi N (2001) The role of paxo in brain patterning. Tohoku J Exp Med 193:163
Simpson TI, Simpson D (2002) Price, Pax6; a pleiotropic player in development. Bioessays 24:1041–1051
Osumi N, Osumi H, Shinohara K, Numayama Tsuruta M Maekawa M (2008)Concise review: Pax6 transcription factor contributes to both embryonic and adult neurogenesis as a multifunctional regulator. Stem Cells 26:1663–1672
Sakurai K, Osumi N (2008) The neurogenesis-controlling factor, Pax6, inhibits proliferation and promotes maturation in murine astrocytes. J Neurosci 28:4604–4612
Andersson E, Tryggvason U, Deng Q, Friling S, Alekseenko Z, Robert B et al (2006) Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124:393–405
Ang S-L (2006) “Transcriptional control of midbrain dopaminergic neuron development”. Development 133:3499–3506
Mikkola I, Bruun JA, Holm T, Johansen T (2001) Superactivation of Pax6-mediated transactivation from paired domain-binding sites by dna-independent recruitment of different homeodomain proteins. J Biol Chem 276:4109–4118
Subramanian L, Sarkar A, Shetty A, Muralidharan B, Padmanabhan H, Piper M et al (2011) Transcription factor Lhx2 is necessary and sufficient to suppress astrogliogenesis and promote neurogenesis in the developing hippocampus. Proc Natl Acad Sci USA 108:E265–E274
Hou P-S, Chuang C-Y, Kao C-F, Chou S-J, Stone L, Ho H-N et al (2013) LHX2 regulates the neural differentiation of human embryonic stem cells via transcriptional modulation of PAX6 and CER1. Nucleic Acids Res 41:7753–7770
Zhang L, Zhang P, Mathers M, Jamrich M (2000) Function ofRx, but notPax6, is essential for the formation of retinal progenitor cells in mice. Genesis 28:135–142
Sasai Y (1998) Identifying the missing links: genes that connect neural induction and primary neurogenesis in vertebrate embryos. Neuron 21:455–458
Bendall A, Bendall D, Rincon Limas J, Botas C, Abate S (1998) Protein complex formation between Msx1 and Lhx2 homeoproteins is incompatible with DNA binding activity. Differentiation 63:151–157
Visvader MJ (2003) LIM-domain-binding protein 1: a multifunctional cofactor that interacts with diverse proteins. EMBO Rep 4:1132–1137
Dreyer SD, Morello R, German MS, Zabel B, Winterpacht A, Lunstrum GP et al (2000) LMX1B transactivation and expression in nail-patella syndrome. Hum Mol Genet 9:1067–1074
Jurata LW, Pfaff SL, Gill GN (1998) “The nuclear LIM domain interactor NLI mediates homo- and heterodimerization of LIM domain transcription factors. J Biol Chem 273:3152–3157
Ravasi T, Ravasi H, Suzuki C, Cannistraci S, Katayama V, Bajic K et al (2010) An atlas of combinatorial transcriptional regulation in mouse and man. Cell 140:744–752
Kempermann G, Chesler E, Lu L, Williams R, Gage F (2006) Natural variation and genetic covariance in adult hippocampal neurogenesis. Proc Natl Acad Sci USA 103:780–785
Waldmann T, Waldmann E, Rempel N, Balmer A, König R, Kolde J et al (2014) Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol 27:408–420
Krug A, Krug R, Kolde J, Gaspar E, Rempel N, Balmer K et al (2013) Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol 87:123–143
Balmer N, Balmer S, Klima E, Rempel V, Ivanova R, Kolde M et al (2014) From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol 88:1451–1468
Balmer N, Weng M, Zimmer B, Ivanova V, Chambers S, Nikolaeva E et al (2012) Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. Hum Mol Genet 21:4104–4114
Laeng RL, Pitts AL, Lemire CE, Drabik A, Weiner H, Tang R et al (2004) The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 91:238–251
Hao Y, Creson T, Zhang L, Li P, Du F, Yuan P et al (2004) Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J Neurosci 24:6590–6599
Yu J-Y, Park SH, J.-s. Kim, Lee Y-S (2009) and Son, Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Neuropharmacology 56:473–480
Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH (2004) Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci USA 101:16659–16664
Liu XS, Chopp H, Kassis LF, Jia A, Hozeska-Solgot RL, Zhang C et al (2012) Valproic acid increases white matter repair and neurogenesis after stroke. Neuroscience 220:313–321
Umka J, Mustafa S, ElBeltagy M, Thorpe A, Latif L, Bennett G et al (2010) Valproic acid reduces spatial working memory and cell proliferation in the hippocampus. Neuroscience 166:15–22
Jessberger S, Nakashima K, Clemenson GD, Mejia E, Mathews E, Ure K et al (2007) Epigenetic modulation of seizure-induced neurogenesis and cognitive decline. J Neurosci 27:5967–5975
Monti B, Gatta V, Piretti F, Raffaelli SS, Virgili M, Contestabile A (2010) Valproic acid is neuroprotective in the rotenone rat model of Parkinson’s disease: involvement of α-synuclein. Neurotox Res 17:130–141
Kidd SK, Schneider JS (2011) Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease. Neuroscience 194:189–194
Mahmoud F, Tampi RR (2011) Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature. Am J Geriatr Pharmacother 9:405–412
Silver SA (2013) Factor valproic acid-induced parkinsonism: Levodopa responsiveness with dyskinesia. Parkinsonism Relat Disord 19:758–760
Acknowledgements
This work was supported by a grant from the National Health and Medical Research Council of Australia.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Farzanehfar, P., Horne, M.K. & Aumann, T.D. Can Valproic Acid Regulate Neurogenesis from Nestin+ Cells in the Adult Midbrain?. Neurochem Res 42, 2127–2134 (2017). https://doi.org/10.1007/s11064-017-2259-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-017-2259-z